inflammation Press Release

Title Picture
10/17/2018 - 17:26
Researchers identify immune culprits linked to inflammation and bone loss in gum disease
NIH's picture
10/16/2018 - 13:45
Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx leadership in spondyloarthritis
Novartis's picture
10/16/2018 - 06:24
Dupixent (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps
Genzyme's picture
10/15/2018 - 18:53
New Immunotherapy Targeting Blood-Clotting Protein Protects Multiple Sclerosis and Alzheimers Disease Models
Gladstone Institutes's picture
Gladstone Institutes
10/15/2018 - 15:05
Message from the Deputy Chairman of the Board
Chugai's picture
10/15/2018 - 11:21
New Meatless Campaign Targets Vital Importance of Kidneys to Overall Health
National Kidney Foundation's picture
National Kidney...
10/15/2018 - 06:38
Sugar, a sweet tool to understand brain injuries
ANUniversity's picture
10/14/2018 - 17:56
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment
Genentech's picture
10/12/2018 - 19:35
UWA awarded $490,000 to research muscular dystrophy drug
UWA's picture
10/11/2018 - 20:51
Breadth of data at ECTRIMS underpins Novartis' relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden
Novartis's picture
10/11/2018 - 17:16
BrightFocus Foundation Expands Scientific Team
BrightFocus Foundation's picture
BrightFocus Fou...
10/11/2018 - 14:58
Theravance Biopharma and Mylan Report Positive New Data from Multiple Studies of YUPELRI (revefenacin) at the 2018 CHEST Annual Meeting
Mylan's picture
10/10/2018 - 18:35
Sanofi Presents 8-Year Data on Lemtrada (Alemtuzumab)
Genzyme's picture
10/10/2018 - 16:49
Study identifies gene that makes gentle touch feel painful after injury
NIH's picture
10/10/2018 - 15:46
Microbiome profiling reveals associations with ulcerative colitis severity, treatment
Broad Institute's picture
Broad Institute
10/10/2018 - 10:35
New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018
Celgene's picture
10/10/2018 - 09:46
New study finds that inflammatory proteins in the colon increase incrementally with weight
TuftsNow's picture
10/09/2018 - 21:14
Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya over Copaxone in patients with relapsing remitting multiple sclerosis
Novartis's picture
10/09/2018 - 17:14
OCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces Disability Progression over Five Years in Relapsing and Primary Progressive Multiple Sclerosis
Genentech's picture
10/09/2018 - 09:33
Dannie Durand Receives NSF "Understanding Rules of Life" Grant
CarnegieMellon's picture
10/08/2018 - 20:35
Recovering from a heart attack? Hold the antibiotics
University of Wisconsin's picture
University of W...
10/08/2018 - 19:48
Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder
UTSouthwestern's picture
10/08/2018 - 19:01
Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients
Novartis's picture
10/08/2018 - 18:50
NIH research projects to track activities of gut-derived metabolites
NIH's picture
10/08/2018 - 17:22
Old drug could have new use helping sick premature babies
UWA's picture
10/07/2018 - 21:17
More Than 30 Data Presentations from Sanofi Genzymes Multiple Sclerosis Franchise to Be Featured at the 34th ECTRIMS Congress
Genzyme's picture
10/07/2018 - 19:52
Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI (revefenacin) at the 2018 CHEST Annual Meeting
Mylan's picture
10/04/2018 - 22:15
Racial discrimination linked to higher risk of chronic illness in African American women
University of Berkeley's picture
University of B...
10/04/2018 - 17:41
Stem Cells Could Be the Key to Treating Severe Blistering Disease, RDEB
New York Medical College's picture
New York Medica...
10/04/2018 - 13:34
#CalfHealth Campaign - Part 3 Having trouble with calf pneumonia on your farm?
Ulster Farmers Union's picture
Ulster Farmers Union
10/03/2018 - 09:15
Gosens wins the Prix Galien Research Award 2018
University of Groningen's picture
University of G...
10/02/2018 - 22:45
Periodontal disease bacteria may kick-start Alzheimers
UICUniv's picture
10/01/2018 - 14:43
Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple Sclerosis at ECTRIMS
Genentech's picture
09/28/2018 - 10:26
How a sleeping cancer awakens and metastasizes
CSHL's picture
09/28/2018 - 09:55
Sickle Cell Disease: Symptoms, Treatment and Management
Cone Health's picture
Cone Health
09/28/2018 - 04:57
FDA Approves Genentech's Xolair (Omalizumab) Prefilled Syringe Formulation
Genentech's picture
09/27/2018 - 05:14
Therapy applied directly inside the eye best for treating uveitic macular edema
NIH's picture
09/27/2018 - 01:52
Pathomechanisms deciphered for the two most common age-related eye disorders
HelsinkiUniv's picture
09/26/2018 - 22:06
A virus with no vaccine, treatment is in the UTMB research crosshairs
UTMB's picture
09/26/2018 - 09:55
A Blueprint to Beat Breast Cancer
AICR's picture
09/25/2018 - 08:21
Expert Suggests which Foods to Embrace & Avoid to Ease Anxiety
Groff Hinman's picture
Groff Hinman
09/23/2018 - 19:39
Know Someone Sick? Your Own Smell Might Give It Away
Monell's picture
09/21/2018 - 04:42
Manchester dementia researchers awarded 200,000 funding boost
Alzheimers Research's picture
Alzheimers Research
09/21/2018 - 04:26
Southampton gets 125k dementia research funding boost
Alzheimers Research's picture
Alzheimers Research
09/21/2018 - 00:35
Novartis receives positive CHMP opinion for Gilenya for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe
Novartis's picture
09/20/2018 - 23:00
World Alzheimers Day: Reflecting on Progress and a Need for Collaboration Among Patients, Caregivers and the Drug Development Industry to Advance New Treatments
PAREXEL's picture
09/20/2018 - 11:54
Mylan and Fujifilm Kyowa Kirin Biologics receive european marketing authorization for Hulio, Biosimilar Adalimumab.
Fujifilm's picture
09/20/2018 - 11:39
Rice University bioengineers combine forces to fight Type-1 diabetes
JDRF's picture
09/20/2018 - 01:29
Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio, Biosimilar Adalimumab
Mylan's picture
09/20/2018 - 00:38
Insulin Shows Great Potential Against Chronic Colitis
UniversityofCopenhagen's picture
09/19/2018 - 22:14
Epigenetic Signature May Help People Stay Ahead of IBD
Cincinnati Childrens's picture
Cincinnati Childrens
09/19/2018 - 13:53
Undiagnosed STIs can increase negative PMS symptoms
UniversityOfOxford's picture
09/18/2018 - 13:03
The microbiota in the intestines fuels tumour growth
Technical University of Munich's picture
Technical Unive...
09/18/2018 - 12:41
'Significant breakthrough' in understanding the deadly nature of pandemic influenza
University of Cambridge's picture
University of C...
09/18/2018 - 10:55
Hospital admissions for sepsis in Finger Lakes region is higher than upstate NY average
Excellus BlueCross BlueShield's picture
Excellus BlueCr...
09/18/2018 - 10:04
Blood test boost for dairy industry
Elmwood College's picture
Elmwood College
09/17/2018 - 03:47
Print Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
Mylan's picture
09/15/2018 - 11:51
Positive Phase 3 results presented for Dupixent (dupilumab) show significant improvement on multiple measures of disease severity in adolescents with moderate-to-severe atopic dermatitis
Genzyme's picture
09/14/2018 - 00:14
UCL academics win awards at Health Humanities Medal
UniversityCollegeLondon's picture
09/13/2018 - 18:58
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Genentech's picture